Belgia - Prancis - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

inibsa dental s.l.u. - bitartrate d'epinéphrine 9 µg/ml - eq. epinéphrine 5 µg/ml; chlorhydrate d'articaïne 40 mg/ml - solution injectable - 40 mg/ml - 0,005 mg/ml - chlorhydrate d'articaïne 40 mg/ml; bitartrate d'epinéphrine 9 µg/ml - articaine, combinations

Belgia - Prancis - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

septodont sa-nv - bitartrate d'epinéphrine 9,1 µg/ml - eq. epinéphrine 5 µg/ml; chlorhydrate d'articaïne 40 mg/ml - solution injectable - 40 mg/ml - 5 µg/ml - bitartrate d'epinéphrine 9.1 µg/ml; chlorhydrate d'articaïne 40 mg/ml - articaine, combinations

Belgia - Prancis - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

septodont sa-nv - bitartrate d'epinéphrine 18,2 µg/ml - eq. epinéphrine 10 µg/ml; chlorhydrate d'articaïne 40 mg/ml - solution injectable - 40 mg/ml - 10 µg/ml - bitartrate d'epinéphrine 18.2 µg/ml; chlorhydrate d'articaïne 40 mg/ml - articaine, combinations

Uni Eropa - Prancis - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Uni Eropa - Prancis - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).

Prancis - Prancis - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

sanofi aventis france - chlorhydrate d'articaïne - solution - 40 mg - composition pour 1 ml de solution injectable > chlorhydrate d'articaïne : 40 mg > adrénaline : 0,005 mg - anesthésiques locaux, amides

Prancis - Prancis - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

sanofi aventis france - chlorhydrate d'articaïne - solution - 40 mg - composition pour 1 ml de solution injectable > chlorhydrate d'articaïne : 40 mg > adrénaline : 0,01 mg - anesthésiques locaux, amides

Prancis - Prancis - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

3m espe ag - chlorhydrate d'articaïne - solution - 40 mg - composition pour 1 ml de solution injectable > chlorhydrate d'articaïne : 40 mg > adrénaline : 2,5 microgrammes . sous forme de : chlorhydrate d'adrénaline - anesthésiques, locaux

Uni Eropa - Prancis - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Kanada - Prancis - Health Canada

hansamed limited - Épinéphrine; chlorhydrate d'articaïne - solution - 5mcg; 40mg - Épinéphrine 5mcg; chlorhydrate d'articaïne 40mg - local anesthetics